Vaxzevria (previously COVID-19 Vaccine AstraZeneca)-H-C-PSUSA-00010912-202206: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
scientific-conclusion
medication.label.permit_number
EMA/38839/2023
medication.label.permit_validity
First published: 2023-03-20T12:47:00Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live